Bellicum Pharmaceuticals Inc. (BLCM) Slipped -5.05% or -0.16 To Price $2.92 On Friday

Bellicum Pharmaceuticals Inc. (BLCM) slipped -5.05% or -0.16 to $2.92. It is near 226746 shares traded, which is 51.85% compare to the average total volume 437312. The market cap of BLCM is $134.12 million. The year to date change is -12.86%. The 52 week price range is from $2.74 to $10.26. Price of BLCM have changed -0.65% during last week. It have changed -10.50% over last month, -5.83% over last 3 months, -27.08% over last 6 months and -62.47% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BLCM is 3.32. It is 13.70% above current price. The 200-day Moving Averages for BLCM is 4.36. It is 49.32% above current price. The 52-week High is 10.26. It is 251.37% from the current price. The 52-week Low is 2.74. It is -6.16% from current price.

There are some statistics of BLCM. It is has market cap $134.12 million. The share outstanding is 46.01 million. The average volume is 437312. The percent of top 15 Institution holding is 66.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BLCM is -170.41%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BLCM is -88.83%.


Share this post